Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

Exercise of Options and Director Dealing

6 Dec 2018 07:00

RNS Number : 5599J
Surface Transforms PLC
06 December 2018
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

Surface Transforms plc

 

("Surface Transforms" or the "Company")

 

Exercise of Options and Director Dealing

 

Surface Transforms plc (AIM: SCE) announces that the Company was notified on 5 December 2018 that Dr Kevin Johnson (CEO of Surface Transforms Plc) exercised options over 675,000 ordinary shares of 1p each in the Company ("Ordinary Shares").

 

Specifically, on 5 December 2018, Dr Kevin Johnson purchased 345,000 Ordinary Shares at a price of 9p per Ordinary Share and purchased 330,000 Ordinary Shares at a price of 11.5p.

 

Following the above transactions, Dr Johnson will be beneficially interested in 799,000 Ordinary Shares, which equates to approximately 0.6 per cent. of the Company's total issued share capital.

 

Dr Johnson has advised that he intends to transfer all of these shares to his SIPP but this will not change his beneficial interest in the Company.

 

Admission and Total Voting Rights

 

The new Ordinary Shares will, when issued, rank pari passu in all respects with the existing Ordinary Shares of the Company. Application will be made for the 675,000 new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence at 8.00 a.m. on 11 December 2018. Following Admission, the total number of voting rights in the Company will be 123,710,416 and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

- Ends -

 

 

 

For enquiries, please contact:

Surface Transforms plc

 

 

Kevin Johnson, CEO

Michael Cunningham CFO

 

+44 151 356 2141

+44 151 348 8882

David Bundred, Chairman

+44 7785 388 848

 

Cantor Fitzgerald Europe (Nomad & Joint-Broker)

+44 20 7894 7000

David Foreman, Richard Salmond, Michael Boot (Corporate Finance)

Caspar Shand Kydd, Gregor Paterson (Sales)

 

 

 

FinnCap Ltd (Joint-Broker)

+44 20 7220 0500

Richard Chambers (Corporate Broking)

Ed Frisby / Giles Rolls (Corporate Finance)

 

 

 

For further Company details, visit www.surfacetransforms.com.

 

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulations, provides further detail in respect of the transaction as described above.

 

 

 

 

Notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities ("PDMR") and persons closely associated with them ("PCA")

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Dr Kevin Johnson

2

Reason for notification

 

 

 

a.

Position/Status

PDMR

CEO

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Surface Transforms plc

b.

LEI

213800GQHNJPE5O8XO79

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares of 1p each 

ISIN: GB0002892528

b.

Nature of the transaction

Purchase of 675,000 ordinary shares of 1p each in the Company ("Ordinary Shares).

 

c.

Price(s) and volume(s)

- Transaction 1 (Purchase)

 

- Transaction 2

(purchase)

 

Price(s)

Volume(s)

9.00p

345,000

11.5p

330,000

 

d.

Aggregated information

- Transaction 1

(purchase)

 

- Transaction 2

(purchase)

Price(s)

Aggregated volume(s)

Aggregated Total

9p

345,000

£31,050.00

11.5p

330,000

£37,950.00

 

e.

Date of the transaction

5/12/2018

f.

Place of the transaction

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUGGPCPUPRGWA
Date   Source Headline
26th May 20267:00 amRNSCancellation - Surface Transforms plc
22nd Apr 20264:31 pmRNSDisclosure Table
22nd Apr 20264:04 pmRNSAdministrators Appointed, End of FSP &Resignations
10th Apr 20263:27 pmRNSForm 8.3 - Surface Transforms Plc
9th Apr 20263:49 pmRNSNotice of Intention to Appoint Administrators
7th Apr 20262:38 pmRNSForm 8.3 - Surface Transforms PLC
1st Apr 202610:41 amRNSForm 8.3 - Surface Transforms PLC
30th Mar 20266:33 pmRNSForm 8.3 - Surface Transforms PLC
30th Mar 202610:08 amRNSForm 8.3 - Surface Transforms PLC
30th Mar 202610:07 amRNSForm 8.3 - Surface Transforms PLC
27th Mar 20262:00 pmRNSForm 8.3 - Surface Transforms plc
25th Mar 20263:43 pmRNSUpdate on Intention to Appoint Administrators
23rd Mar 20262:13 pmRNSForm 8.3 - Surface Transforms plc
20th Mar 202611:26 amRNSForm 8.3- Surface Transforms plc
20th Mar 20267:43 amRNSDisclosure Table
20th Mar 20267:30 amRNSContract Update, Launch of Strategic Review & FSP
12th Mar 20266:00 pmRNSSurface Transforms
12th Mar 202612:35 pmRNSContract update, suspension of trading and NOIA
3rd Mar 20261:32 pmRNSMajor Customer Update: Loss of Contract
19th Jan 20267:00 amRNSTrading and operations update
27th Nov 202512:03 pmRNSHolding(s) in Company
27th Nov 20257:00 amRNSAward of 2025 LTIP share options
9th Oct 20251:40 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSInterim Results and Trading Update
19th Sep 20257:00 amRNSChange from interim to permanent CFO
15th Sep 20258:34 amRNSHolding(s) in Company
5th Sep 20257:00 amRNSAppointment of Non-Executive Director
28th Aug 202511:58 amRNSHolding(s) in Company
22nd Jul 20252:59 pmRNSResult of AGM
22nd Jul 20257:00 amRNSTrading and operational progress update
12th Jun 20254:17 pmRNSDirector/PDMR Shareholding
12th Jun 202512:51 pmRNSDirector/PDMR Shareholding
11th Jun 20258:35 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSYear end results and Notice of AGM
22nd May 20253:53 pmRNSChange from interim to permanent Non-Exec Chair
14th May 20255:27 pmRNSHolding(s) in Company
7th May 202511:33 amRNSHolding(s) in Company
6th May 202511:30 amRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSShare Incentive Plan – Allocation of Share
25th Apr 202511:30 amRNSHolding(s) in Company
2nd Apr 20257:00 amRNSFinancing, trading and operations update
7th Mar 20259:36 amRNSHolding(s) in Company
6th Mar 20255:40 pmRNSHolding(s) in Company
6th Mar 20257:00 amRNSCFO retirement
28th Feb 202511:47 amRNSHolding(s) in Company
5th Feb 20257:00 amRNSHolding(s) in Company
4th Feb 20252:15 pmRNSFinancing, trading and operations update
17th Jan 20251:02 pmRNSHolding(s) in Company
15th Jan 20251:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.